Sysmex America, Inc.

Sysmex America, Inc., a foreign-owned, for-profit manufacturer and distributor of clinical laboratory diagnostic equipment and reagents, operates as a prime contractor across federal healthcare agencies without small business set-aside designation, delivering hematology analyzers, urinalysis systems, reagents, and comprehensive maintenance services on predominantly cost-per-reportable-result and cost-per-test bases.

Sysmex America is the U.S. subsidiary of Japan-headquartered Sysmex Corporation, operating from Lincolnshire, Illinois. The company competes as a large business in the open federal marketplace across primary NAICS 339112 (Surgical Appliance and Supplies Manufacturing) and secondary NAICS 334516 (Analytical Laboratory Instrument Manufacturing), with PSC concentration in Laboratory Equipment and Supplies (PSC 6520). Recent awards span four thousand one hundred ninety-eight prime contracts and deliveries across four primary federal healthcare customer agencies, with combined potential value of one point sixty-six billion dollars. The vendor has obligated approximately three hundred ninety-eight point nine million dollars (24 percent of potential value) and received approximately eighty-seven awards through October 2026.

Customer concentration heavily favors the Department of Veterans Affairs ecosystem. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network (VISN) 12 dominates both count and dollars: two hundred thirty-six awards valued at five hundred seventy-three point three million dollars combined potential value. VISN 9 ranks second by dollars (two hundred fifty-five point eight million across one hundred twenty-nine awards), followed by the Defense Health Agency (two hundred eleven awards, ninety-two point six million), VISN 8 (one hundred seven awards, fifty-nine point three million), and VISN 2 (one hundred one awards, forty-nine point six million). These five customers account for approximately 62 percent of combined potential value. The Indian Health Service (five hundred fifty-six awards) and Defense Logistics Agency Troop Support Medical (three hundred thirty-two awards) anchor volume but carry substantially smaller dollar values, demonstrating Sysmex's VA-centric revenue profile alongside transaction-heavy DLA relationships.

Vehicle position centers on the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III), a thirty-point ninety-seven million dollar contract effective through December 14, 2029, which anchors one thousand seven hundred sixteen task orders valued at six hundred thirty-two million dollars combined potential value. This schedule serves as the parent vehicle for the vast majority of Sysmex's federal work, enabling streamlined delivery orders and BPA calls across multiple VISN networks, the Defense Health Agency, Indian Health Service, and other federal healthcare entities. Secondary vehicles include Federal Supply Schedule V797P4709A (one thousand thirty task orders, one hundred forty-nine point eight million dollars) and the Multiple Award Schedule (two hundred sixty-four task orders, twenty-three point four million dollars). Sysmex also holds multiple single-award BPAs directly with individual VISN networks, including VISN 2 (five point ninety-two million dollars, effective through September 30, 2027), VISN 1 (seven point three million dollars, effective through July 31, 2031), VISN 8 (nine point seven million dollars, effective through September 30, 2030), and IHS Phoenix Indian Medical Center (one point five million dollars, effective through August 1, 2030).

Activity has remained stable year over year—two hundred fifty-three to two hundred sixty-four awards annually from 2022 through 2025—with eighty-seven awards awarded through October 2026. Two hundred thirteen awards with ultimate completion dates within the next twenty-four months carry combined potential value of fifty-eight point two million dollars, representing moderate recompete exposure centered on VISN-specific delivery orders and BPA calls that renew on rolling fiscal-year or calendar-year schedules rather than discrete recompete events.

Sysmex's federal capability portfolio is concrete and equipment-centric: hematology analyzers (XN-1000, XN-3100, XN1000BB models), urinalysis analyzers, coagulation testing systems, digital morphology solutions (CellaVision DI60), reagents and consumables, quality controls, calibration kits, and comprehensive maintenance and technical support. Representative work includes a nine point six million dollar firm fixed-price delivery order from the Defense Health Agency for cost-per-reportable-result hematology analyzer services at Prairie View, Illinois (through September 30, 2030); a five hundred seventy-three point three million dollar combined portfolio with VISN 12 spanning hematology cost-per-reportable-result services, analyzers, reagents, and maintenance; a three hundred eighty-six thousand dollar delivery order from Indian Health Service for hematology analyzers, reagents, controls, consumables, and maintenance at Rosebud and Pine Ridge facilities (through November 30, 2030); and multiple one-million-plus single-award BPAs with VISN 9 (seven point one nine million), VISN 19 (seven point seven million), and VISN 8 (nine point seven million). Cost-per-reportable-result and cost-per-test pricing structures are standard across VA work; firm fixed-price applies to equipment purchases and maintenance agreements.

Sysmex operates entirely as prime contractor in recent awards—4,196 of 4,198 total awards carry prime designation—with negligible subcontract footprint (two sub-awards total). One sub-award, from November 2025, names KBR Wyle Services, LLC as prime contractor for a hematology analyzer delivery under HHPC2; the second sub-award context is insufficient in the source. This posture reflects the company's original equipment manufacturer status and direct relationships with federal healthcare customers across contracting vehicles.

The vendor's federal healthcare focus is absolute: all primary customers are the Department of Veterans Affairs VISN networks, Defense Health Agency, Indian Health Service, NIH Clinical Center, Federal Bureau of Prisons healthcare, and Department of Justice correctional healthcare. Sysmex has registered with SAM.gov since July 2003 and maintains a stable, mature federal contracting operation delivering specialized laboratory diagnostic equipment on streamlined, cost-based pricing models tailored to federal healthcare operations. No small business certifications, state of incorporation details, or change-of-ownership signals appear in the source material.